Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 known ✓ | P41231 | 4/20 | 0.66 |
| ▸ | P2RY4 known ✓ | P51582 | 2/20 | 0.66 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.62 |
| ▸ | P2RY6 known ✓ | Q15077 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.81 |
| ▸ | GLA | P06280 | 1/20 | 0.81 |
| ▸ | ST6GAL1 | P15907 | 10/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | MTOR | P42345 | 1/20 | 0.62 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.62 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.62 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5407898 | 1.00 | TSHR (0.81) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Potassium Ion SCHEMBL10585798 | 0.99 | TSHR (0.80) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL9101211 | 0.98 | TSHR (0.81) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL31405617 | 0.97 | TSHR (0.80) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL10826769 | 0.97 | TSHR (0.80) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| SCHEMBL11616961 | 0.94 | TSHR (0.78) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL2194120 | 0.92 | TSHR (0.79) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cystetine Triphosphate SCHEMBL11613107 | 0.92 | TSHR (0.79) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Choline SCHEMBL503814 | 0.92 | TSHR (0.81) | TSHRGLAST6GAL1P2RY2P2RY4 | |
| Cytarabine 5'-Phosphate SCHEMBL859798 | 0.92 | TSHR (0.74) | TSHRGLAST6GAL1P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600997-B2 | Fermentative production of sialylated saccharides | CHR. HANSEN A/S (DK) | 2026-04-14 | — | — | US | claimed |
| EP-4686760-A1 | SIALYLTRANSFERASES FOR THE SYNTHESIS OF SIALYLATED GLYCANS, GLYCOCONJUGATES AND GLYCOPROTEINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-02-04 | — | — | EP | claimed |
| US-20250263678-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | REJUVENATION TECHNOLOGIES, INC. (US) | 2025-08-21 | — | — | US | claimed |
| EP-3350333-B2 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNATX INC (US) | 2025-08-06 | — | — | EP | claimed |
| US-20250243525-A1 | BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2025-07-31 | — | — | US | claimed |
| US-12275973-B2 | Enzymatic method for preparation of CMP-Neu5Ac | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2025-04-15 | — | — | US | claimed |
| CN-119552932-A | Preparation method of cytidine-5' -diphosphate | 上海日冠生物科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| EP-3337488-B1 | TREATMENT AND PREVENTION OF NEISSERIA GONORRHOEAE INFECTION USING CMP-ACTIVATED NONULOSONATE ANALOG COMPOUNDS | NAT RES COUNCIL CANADA (CA) | 2024-12-18 | — | — | EP | claimed |
| US-20240352497-A1 | ENZYMATIC METHOD FOR PREPARATION OF CMP-NEU5AC | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2024-10-24 | — | — | US | claimed |
| US-20240327447-A1 | CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID | 89BIO, INC. (US) | 2024-10-03 | — | — | US | claimed |
| WO-2023122616-A1 | CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID | 89BIO, INC. (US) | 2023-06-29 | — | — | WO | claimed |
| US-20230174991-A1 | KDO-FREE PRODUCTION HOSTS FOR OLIGOSACCHARIDE SYNTHESIS | INBIOSE N.V. (BE) | 2023-06-08 | — | — | US | claimed |
| WO-2023026449-A1 | METHOD FOR PRODUCING CYTIDINE 5'-DIPHOSPHATE COMPOUND | 協和発酵バイオ株式会社 | 2023-03-02 | — | — | WO | claimed |
| WO-2023027178-A1 | METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND | 協和発酵バイオ株式会社 | 2023-03-02 | — | — | WO | claimed |
| CN-115644334-A | Preparation method of ginseng and gorgon fruit fermented beverage | 江西水圣实业有限公司 | 2023-01-31 | — | — | CN | claimed |
| WO-2022263489-A1 | NUCLEOSIDE-5 -OLIGOPHOSPHATES HAVING A CATIONICALLY-MODIFIED NUCLEOBASE | F. HOFFMANN-LA ROCHE AG (CH) | 2022-12-22 | — | — | WO | claimed |
| EP-4103730-A1 | ENZYMATIC METHOD FOR PREPARATION OF CMP-NEU5AC | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-12-21 | — | — | EP | claimed |
| US-20220396761-A1 | VIABLE BACTERIAL HOST CELL | INBIOSE N.V. (BE) | 2022-12-15 | — | — | US | claimed |
| EP-3575404-B1 | FERMENTATIVE PRODUCTION OF SIALYLATED SACCHARIDES | CHR HANSEN HMO GMBH (DE) | 2022-10-19 | — | — | EP | claimed |
| WO-2022147039-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | REJUVENATION TECHNOLOGIES INC. (US) | 2022-07-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263678-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | RNASE1, POLRMT, TERT | P2RY2 4635/4885P2RY4 4783/4885THRB 897/4885 |
| US-12600997-B2 | Fermentative production of sialylated saccharides | RNGTT, NANS, ENGASE | P2RY2 3098/4885P2RY4 2219/4885THRB 913/4885 |
| US-20240327447-A1 | CHEMICAL SYNTHESIS OF CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC ACID | NEU2, NEU1, FUT5 | P2RY2 839/4885P2RY4 822/4885THRB 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.